Stem Cells, Vol 13, 524-532, Copyright © 1995 by AlphaMed Press

ORIGINAL ARTICLES

Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems

EA de Wynter, LH Coutinho, X Pei, JC Marsh, J Hows, T Luft and NG Testa
Cancer Research Campaign Department of Experimental Haematology, Paterson Institute for Cancer Research, Manchester, United Kingdom.

Interest in the isolation and characterization of primitive hemopoietic cells in both the clinical and research fields has rapidly increased. In parallel, different purification systems have been developed to isolate these cells. We have compared five different methods for separation of CD34+ cells from human umbilical cord blood, normal bone marrow and apheresis harvests and analyzed purity, recovery, yield and enrichment of colony forming cells (CFC) for each individual system. Our results indicate that the most reliable methods of purification for all samples were fluorescence activated cell sorting (FACS) and magnetic activated cell sorting (MACS) which consistently yielded high purities (> 70%) and enrichment of CFC. In this respect the enrichment of CFC from the MACS was superior to all the other systems including FACS. Similar results (> 70%) for purity were obtained using avidin affinity columns and a biotinylated antibody but neither yield nor CFC enrichment approached the values achieved with MACS. On average CFC enrichment using these affinity columns was greater than that observed for FACS while the purity was comparable. Both CELLector flasks and immunomagnetic beads coated with CD34 antibodies were less effective in our hands in separating purified populations of progenitor cells. Both purity and CFC enrichment of CD34+ cells using these methods were at least 50% lower than obtained with either FACS, MACS or affinity columns.

This article has been cited by other articles:

				S. Emadi, D. Clay, C. Desterke, B. Guerton, E. Maquarre, A. Charpentier, C. Jasmin, M.-C. Le Bousse-Kerdiles, and for the French INSERM Research Network on MMM IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis Blood, January 15, 2005; 105(2): 464 - 473. [Abstract] [Full Text] [PDF]

				G.-H. Schernthaner, J.-H. Jordan, M. Ghannadan, H. Agis, D. Bevec, R. Nunez, L. Escribano, O. Majdic, M. Willheim, C. Worda, et al. Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells Blood, December 15, 2001; 98(13): 3784 - 3792. [Abstract] [Full Text] [PDF]

				M. E. Merino, F. Navid, B. L. Christensen, J. A. Toretsky, L. J. Helman, N.-K. V. Cheung, and C. L. Mackall Immunomagnetic Purging of Ewing's Sarcoma From Blood and Bone Marrow: Quantitation by Real-Time Polymerase Chain Reaction J. Clin. Oncol., August 15, 2001; 19(16): 3649 - 3659. [Abstract] [Full Text] [PDF]

				M. T. Smith, L. Zhang, M. Jeng, Y. Wang, W. Guo, P. Duramad, A. E. Hubbard, G. Hofstadler, and N. T. Holland Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells Carcinogenesis, August 1, 2000; 21(8): 1485 - 1490. [Abstract] [Full Text] [PDF]

				E.A. de Wynter, J. Durig, M.A. Cross, C.M. Heyworth, and N.G. Testa Differential Response of CD34+ Cells Isolated from Cord Blood and Bone Marrow to MIP-1{alpha} and the Expression of MIP-1{alpha} Receptors on These Immature Cells Stem Cells, September 1, 1998; 16(5): 349 - 356. [Abstract] [Full Text]

				M. J. Clemons, E. Marshall, J. Durig, K. Watanabe, A. Howell, D. Miles, H. Earl, J. Kiernan, A. Griffiths, K. Towlson, et al. A Randomized Phase-II Study of BB-10010 (Macrophage Inflammatory Protein- 1alpha ) in Patients With Advanced Breast Cancer Receiving 5-Fluorouracil, Adriamycin, and Cyclophosphamide Chemotherapy Blood, September 1, 1998; 92(5): 1532 - 1540. [Abstract] [Full Text] [PDF]

				A. H. Yin, S. Miraglia, E. D. Zanjani, G. Almeida-Porada, M. Ogawa, A. G. Leary, J. Olweus, J. Kearney, and D. W. Buck AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells Blood, December 15, 1997; 90(12): 5002 - 5012. [Abstract] [Full Text] [PDF]

				S. Miraglia, W. Godfrey, A. H. Yin, K. Atkins, R. Warnke, J. T. Holden, R. A. Bray, E. K. Waller, and D. W. Buck A Novel Five-Transmembrane Hematopoietic Stem Cell Antigen: Isolation, Characterization, and Molecular Cloning Blood, December 15, 1997; 90(12): 5013 - 5021. [Abstract] [Full Text] [PDF]

				U. Paulus, P. Dreger, K. Viehmann, N. v. Neuhoff, and N. Schmitz Purging Peripheral Blood Progenitor Cell Grafts from Lymphoma Cells: Quantitative Comparison of Immunomagnetic CD34+ Selection Systems Stem Cells, July 1, 1997; 15(4): 297 - 304. [Abstract] [Full Text]

				A. W. Flake, M.-G. Roncarolo, J. M. Puck, G. Almeida-Porada, M. I. Evans, M. P. Johnson, E. M. Abella, D. D. Harrison, and E. D. Zanjani Treatment of X-Linked Severe Combined Immunodeficiency by in Utero Transplantation of Paternal Bone Marrow N. Engl. J. Med., December 12, 1996; 335(24): 1806 - 1810. [Full Text] [PDF]

				E. de Wynter, G Nadali, L. Coutinho, and N. Testa Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets Stem Cells, September 1, 1996; 14(5): 566 - 576. [Abstract]

				H. Hassan, W Zeller, M Stockschlader, W Kruger, M. Hoffknecht, and A. Zander Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection Stem Cells, July 1, 1996; 14(4): 419 - 429. [Abstract]

				F Servida, D Soligo, L Caneva, F Bertolini, E de Harven, S Campiglio, C Corsini, and G. Deliliers Functional and morphological characterization of immunomagnetically selected CD34+ hematopoietic progenitor cells Stem Cells, July 1, 1996; 14(4): 430 - 438. [Abstract]